Left ventricular Doppler characteristics in first-degree relatives of patients with hypertrophic cardiomyopathy

Georgios K Efthimiadis1, Georgios E Parharidis, Haralambos I Karvounis

  • 11st Department of Cardiology, Aristotle University of Thessaloniki, AHEPA Hospital, Greece.

Angiology
|May 13, 2005
PubMed

Insights

Early signs of hypertrophic cardiomyopathy (HCM) may appear in healthy relatives. Doppler echocardiography revealed slower deceleration time in mitral filling, suggesting an early indicator of developing HCM disease.

Area of Science:

  • Cardiology
  • Genetics
  • Echocardiography

Background:

  • Left ventricular (LV) diastolic dysfunction can be an early indicator in hypertrophic cardiomyopathy (HCM).
  • Phenotypic expression of HCM may not always correlate with early functional changes.

Purpose of the Study:

  • To assess LV diastolic performance in asymptomatic first-degree relatives of HCM patients using Doppler echocardiography.
  • To identify early markers of diastolic dysfunction in individuals at high genetic risk for HCM.

Main Methods:

  • Conventional Doppler echocardiography was used to evaluate diastolic function.
  • Key indices included E wave velocity, A wave velocity, E/A ratio, deceleration time, and LV isovolumic relaxation time.
  • Comparison was made between 22 first-degree relatives of HCM patients and 22 healthy controls.

Main Results:

  • A significantly slower deceleration time of transmitral early filling was observed in the relatives group (192 ± 31 msec) compared to controls (149 ± 31 msec).
  • This slower deceleration time was the sole significant differentiator between the two groups.
  • No other conventional echocardiographic parameters or diastolic indices showed significant differences.

Conclusions:

  • Asymptomatic first-degree relatives of HCM patients exhibit an altered mitral filling pattern, similar to that seen in HCM.
  • Slower deceleration time of early filling may serve as a sensitive, early marker for detecting preclinical stages of HCM.
  • Doppler echocardiography can identify subtle diastolic impairments in genetically predisposed individuals before overt disease manifestation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...